BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 33841394)

  • 1. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
    Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
    Front Immunol; 2021; 12():612826. PubMed ID: 33841394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Nenkov M; Ma Y; Gaßler N; Chen Y
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

  • 4. Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps.
    Wu J; Dong W; Pan Y; Wang J; Wu M; Yu Y
    Front Immunol; 2023; 14():1296783. PubMed ID: 37936694
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
    Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
    Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Gut Microbiota in Colorectal Cancer Causation.
    Alhinai EA; Walton GE; Commane DM
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between intestinal microorganisms and T lymphocytes in colorectal cancer.
    Shuwen H; Xi Y; Quan Q; Yuefen P; Miao D; Qing Z
    Future Oncol; 2019 May; 15(14):1655-1666. PubMed ID: 31044617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Colloquy between Microbiota and the Immune System in Colon Cancer: Repercussions on the Cancer Therapy.
    Pal S; Saini AK; Kaushal A; Gupta S; Gaur NA; Chhillar AK; Sharma AK; Gupta VK; Saini RV
    Curr Pharm Des; 2022; 28(43):3478-3485. PubMed ID: 36415093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-colorectal cancer effect and metabolites of Agrimonia pilosa Ledeb.
    Wang L; Chen Q; Song H; Xing W; Shi J; Li Y; Lv Y; Wang Z; Chen J; Zhao W
    J Ethnopharmacol; 2024 Jul; 329():118146. PubMed ID: 38604512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome: decision-makers in the microenvironment of colorectal cancer.
    Han J; Zhang B; Zhang Y; Yin T; Cui Y; Liu J; Yang Y; Song H; Shang D
    Front Cell Infect Microbiol; 2023; 13():1299977. PubMed ID: 38156313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
    Gomes S; Rodrigues AC; Pazienza V; Preto A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer.
    El Tekle G; Andreeva N; Garrett WS
    Annu Rev Physiol; 2024 Feb; 86():453-478. PubMed ID: 38345904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gastrointestinal microbiota in colorectal cancer cell migration and invasion.
    Henstra C; van Praagh J; Olinga P; Nagelkerke A
    Clin Exp Metastasis; 2021 Dec; 38(6):495-510. PubMed ID: 34748126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.